Janus Henderson Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Hold |
34,774
| – | – | ﹤0.01% | 1366 |
|
|
2025
Q1 | $1.29M | Hold |
34,774
| – | – | ﹤0.01% | 1493 |
|
|
2024
Q4 | $1.37M | Hold |
34,774
| – | – | ﹤0.01% | 1514 |
|
|
2024
Q3 | $1.63M | Hold |
34,774
| – | – | ﹤0.01% | 1410 |
|
|
2024
Q2 | $1.88M | Hold |
34,774
| – | – | ﹤0.01% | 1285 |
|
|
2024
Q1 | $2.37M | Hold |
34,774
| – | – | ﹤0.01% | 1213 |
|
|
2023
Q4 | $2.18M | Hold |
34,774
| – | – | ﹤0.01% | 1211 |
|
|
2023
Q3 | $1.58M | Hold |
34,774
| – | – | ﹤0.01% | 1308 |
|
|
2023
Q2 | $1.95M | Hold |
34,774
| – | – | ﹤0.01% | 1259 |
|
|
2023
Q1 | $1.57M | Buy |
34,774
+21,512
| +162% | +$973K | ﹤0.01% | 1391 |
|
|
2022
Q4 | $539K | Sell |
13,262
-13,262
| -50% | -$539K | ﹤0.01% | 1679 |
|
|
2022
Q3 | $1.73M | Buy |
26,524
+11,662
| +78% | +$762K | ﹤0.01% | 1374 |
|
|
2022
Q2 | $903K | Buy |
14,862
+2,989
| +25% | +$182K | ﹤0.01% | 1392 |
|
|
2022
Q1 | $746K | Buy |
+11,873
| New | +$746K | ﹤0.01% | 1666 |
|